Sapanisertib (Compound)

Synonyms:Sapanisertib, 1224844-38-5, INK-128, MLN0128, INK128, INK 128, TAK-228, MLN-0128, INK 128 (MLN0128), 5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine, Sapanisertib (MLN0128), CB-228, JGH0DF1U03, 3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine, 5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine, 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine, Sapanisertib [INN], UNII-JGH0DF1U03, 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)-, 1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, 3-(2-AMINO-5-BENZOXAZOLYL)-1-(1-METHYLETHYL)-, Sapanisertib; INK128, Sapanisertib (USAN/INN), Sapanisertib [USAN:INN], SAPANISERTIB [USAN], MLS006011012, SAPANISERTIB [WHO-DD], GTPL7933, SCHEMBL7902875, CHEMBL3545097, CHEBI:91450, EX-A951, INK-128/INK128, BDBM315477, DTXSID401022538, HMS3656H12, HMS3672C21, INK-128;Sapanisertib;MLN0128, INK-0128, MFCD22124893, NSC764658, NSC768435, NSC780880, s2811, AKOS025149512, US10172858, Table 1.1, BCP9000789, CCG-265002, CS-0557, DB11836, NSC-764658, NSC-768435, NSC-780880, SB16566, 2-Benzoxazolamine, 5-(4-amino-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-, 3-(2-Amino-1,3-benzoxazol-5-yl)-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-4-amine, US10172858, Table 1.22, NCGC00346654-01, NCGC00346654-10, AC-26848, AS-16294, BS170924, HY-13328, SMR004702810, BCP0726000086, FT-0700125, SW220210-1, D11183, INK-128,CAS:1224844-38-5, J-004811, Q27078072, 3-(2-Amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 5-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine, FE5

Pubchem:PUBCHEM:117606729

Id:f7b13b4d-50da-53b1-a7a5-7467666513bc

Description:nan